Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: a Case-Control Study.
CONCLUSION: According to our data complement C3 levels can predict the presence of T2DM in RA patients.
PMID: 29542421 [PubMed - as supplied by publisher]
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Russo E, D'Angelo S, Ammerata G, Abenavoli L, Mauro D, Bruno C, Naty S, Olivieri I, De Sarro G, Ursini F Tags: Rev Recent Clin Trials Source Type: research
More News: Arthritis | Cancer & Oncology | Cardiology | Clinical Trials | Corticosteroid Therapy | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Rheumatoid Arthritis | Rheumatology | Study